You are here

solid tumors

BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya

Fierce Biotech

Fri, 12/13/24 - 11:41 am

Genmab axes 3 programs to focus on plumped-up pivotal pipeline

Fierce Biotech

Thu, 11/7/24 - 11:18 am

Zymeworks doses first subject in Phase I trial of ZW191 for solid tumors

Clinical Trials Arena

Wed, 11/6/24 - 11:29 am

clinical trials

FDA delays decision on Merus' first-in-class cancer drug by 3 months

Fierce Biotech

Tue, 11/5/24 - 10:03 am

Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors

Biopharma Reporter

Tue, 10/22/24 - 11:31 am

clinical trials

Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review

Fierce Biotech

Fri, 10/18/24 - 11:34 am

clinical trials

bispecific antibodies

Transgene’s stock drops after Phase II cancer jab trial misses primary endpoint

Clinical Trials Arena

Thu, 10/17/24 - 09:19 am

clinical trials

cancer vaccines

Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis

Fierce Biotech

Mon, 10/14/24 - 09:47 am

clinical trials

ESMO: Moderna’s mRNA solid tumour vaccine shows early promise

Clinical Trials Arena

Fri, 09/13/24 - 11:04 am

Moderna Therapeutics

Viracta lays off 23% of staff, pauses program to slim down for race to finish line in lymphoma

Fierce Biotech

Wed, 08/14/24 - 11:18 am

Viracta Therapeutics

peripheral T-cell lymphoma

Kezar stalls solid tumor trial to focus on autoimmune disease candidate

Pharmaceutical Technology

Wed, 08/14/24 - 11:05 am

Kezar Life Sciences

clinical trials

autoimmune hepatitis

Halda raises $126M to advance 'hold and kill' solid tumor drugs into the clinic

Fierce Biotech

Mon, 08/12/24 - 11:30 am

Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours

Clinical Trials Arena

Wed, 08/7/24 - 11:16 am

Elevation Oncology

clinical trials

Using AI to improve cell therapies in solid tumors, Outpace clinches $144M

First Word Pharma

Fri, 08/2/24 - 11:54 am

artificial intelligence

J&J vets burst into biotech with $165M Third Arc series A

Fierce Biotech

Tue, 07/23/24 - 11:22 am

autoimmune disease

Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors

BioSpace

Wed, 07/10/24 - 11:11 am

clinical trials

Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC

Fierce Biotech

Tue, 06/18/24 - 11:45 am

Day One Biopharmaceuticals

MabCare Therapeutics

antibody-drug conjugate

FDA approves new Augtyro indication for NTRK-positive tumors

Investing.com

Thu, 06/13/24 - 11:12 pm

Bristol Myers Squibb

ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours

Clinical Trials Arena

Mon, 06/3/24 - 12:06 pm

antibody-drug conjugates

ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study

BioSpace

Fri, 05/24/24 - 11:35 am

clinical trials

bispecific antibodies

Pages